Article
HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument
18 Aug 2015
Abstract excerpt
Limited access to HIV drug resistance testing in low- and middle-income countries impedes clinical decision-making at the individual patient level. An efficient protocol to address this issue must be established to minimize negative therapeutic outcomes for HIV-1-infected individuals in such settings. This is an observational study to ascertain the potential of newer genomic sequencing platforms, such as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
